Results

Total Results: 1,073 records

Showing results for "disease".

241. Aspirin Use Academic Detailing Guide for Practices | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/evidencenow/heart-health/aspirin/detailing.html
     August 01, 2018 - risk, benefits, and recommendations for using aspirin for primary and secondary prevention of heart disease

242. Aspirin Use Treatment Algorithm Decision Tree | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/evidencenow/heart-health/aspirin/algorithm.html
     August 01, 2018 - Health NOW Aspirin Algorithm Resource description: This decision tree for aspirin treatment for heart disease

243. Aspirin Use Care: Tasks for the Practice Facilitator | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/evidencenow/heart-health/aspirin/facilitator-checklist.html
     August 01, 2018 - used with primary care practices to increase aspirin use for secondary prevention of cardiovascular disease

244. EvidenceNow Practice Survey Codebook: Practice Demographics (pdf file)
     www.cpsi.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-demographics.pdf
     August 22, 2018 - would like to understand how your practice uses registries and clinical guidelines for cardiovascular disease … identify services due, gaps in care, or track progress: (Check all that apply) Ischemic vascular disease … determined core item Please identify how your practice uses clinical guidelines for cardiovascular disease … prevention (for example, use of aspirin or antithrombotics for those with ischemic vascular disease … Collaborative…………………………………………demo_prog_mh_collab.. 1 = Yes 2 = No Million Hearts: Cardiovascular Disease

245. Olomu, Adesuwa | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/funding/training-grants/grants/active/kawards/Kawdsumolom.html
     October 01, 2014 - Improve the implementation of evidence-based guidelines for secondary prevention of coronary heart disease … a focus on research to improve the quality of care for blacks and low income populations with heart disease

246. Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/research/findings/studies/index.html
     January 01, 2024 - ) Health Services Research (HSR) (327) Health Status (132) Health Systems (104) Heart Disease … Human Immunodeficiency Virus (HIV) (255) Imaging (245) Implementation (191) Infectious Diseases … Injuries and Wounds (207) Inpatient Care (221) Intensive Care Unit (ICU) (267) Kidney Disease … 133) Screening (457) Sepsis (140) Sex Factors (67) Sexual Health (126) Sickle Cell Disease … Among patients with unfavorable-prognosis disease, external beam radiotherapy with androgen deprivation

247. Addressing Today’s Steep Challenges of Providing High-Quality Behavioral Healthcare | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/news/blog/ahrqviews/high-quality-behavioral-healthcare.html
     December 01, 2022 - care even before the COVID-19 pandemic, fueled by opioid misuse and falling life expectancy due to diseases … Still, more prevalent diseases such as depression, anxiety disorders, and trauma-related conditions continue … The burden of social needs, trauma, physical disease, social drivers of health, and grief compound the

248. Key Study Outcomes Across Grants | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/ncepcr/research-transform-primary-care/transform/synthesis-report/outcomes.html
     October 01, 2015 - using protocols and practices developed for diabetes patients to manage other patients with chronic diseases … Health Outcomes The PCMH model is considered especially well-suited for patients with chronic disease … Five of the TPC studies examined whether the PCMH model fulfilled its promise for chronic disease patients … by measuring the impact of PCMH transformation on two of the most common chronic diseases encountered … in primary care, diabetes and cardiovascular disease.

249. Key Study Outcomes Across Grants | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/ncepcr/reports/grants-transform/key-study-outcomes.html
     March 01, 2017 - using protocols and practices developed for diabetes patients to manage other patients with chronic diseases … Health Outcomes The PCMH model is considered especially well-suited for patients with chronic disease … Five of the TPC studies examined whether the PCMH model fulfilled its promise for chronic disease patients … by measuring the impact of PCMH transformation on two of the most common chronic diseases encountered … in primary care, diabetes and cardiovascular disease.

250. 2023 National Healthcare Quality and Disparities Report (pdf file)
     www.cpsi.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-nhqdr-es-rev.pdf
     January 01, 2023 - global leader in scientific discovery and developing innovative technologies to diagnose and treat disease … preventing chronic Executive Summary 2 2023 National Healthcare Quality and Disparities Report diseases … (4.1%), liver disease (3.0%), and suicide (2.1%). … During the COVID-19 PHE, nursing homes, as one example, were an epicenter of disease activity due to … • Interventions to limit disease transmission, such as isolation or reduced mobility, and shortages

251. Nursing Home Resources | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/es/nursing-home/resources/search.html?page=6
     January 01, 2022 - Stories These stories from long term care facilities focus on key takeaways from implementing Centers for Disease … Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease … The Centers for Disease Control and Prevention (CDC) has updated select healthcare infection prevention

252. Transitioning Newborns from NICU to Home: Family Information Packet, Appendix B (pdf file)
     www.cpsi.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb.pdf
     December 10, 2013 - ■ Infants with significant respiratory disease or congenital heart disease may need a hematocrit … – If the baby is very fluid sensitive (e.g., chronic lung disease), IV lasix 1 mg/kg immediately … Complications ■ Long term TPN use – Hepatobiliary disease. – Catheter-associated sepsis. … ■ Criteria for laser therapy or cryotherapy: – Zone 2: plus disease with stage 2 or 3 ROP. … – Zone 1: plus disease with any stage ROP. – Zone 1: stage 3 ROP with no plus disease.

253. Innovative Adaptation and Dissemination of AHRQ Comparative Effectiveness Research Products | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/prevention/iadapt/index.html
     August 01, 2015 - Prevention Communication Prototypes for the CUIDARSE Project | PDF Version [82 KB] Cardiovascular Disease … AHRQ’s Ischemic Heart Disease Products Translated for High School Populations | PDF Version [309 KB … AHRQ's Ischemic Heart Disease Products Translated for High School Populations | PDF Version [309 KB

254. References | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/ncepcr/tools/assessments/health-ref.html
     September 01, 2013 - A framework for patient-centered health risk assessments—providing health promotion and disease prevention … Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention;2011

255. EvidenceNOW Projects | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/evidencenow/projects/index.html
     September 01, 2022 - investing $18 million over 3 years to four grantees to improve heart health and help reduce cardiovascular disease … public health, and primary care practices in States with the highest rates of preventable cardiovascular disease

256. EvidenceNOW in Action | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/evidencenow/projects/heart-health/about/stories/in-action/index.html
     March 01, 2021 - on these practices and their patients, including identifying and treating patients at risk of heart disease … Implementing Evidence-based Heart Health Care in Asheville "Cardiovascular disease prevention has the

257. EvidenceNOW PCOR Fact Sheet: Aspirin Use Care | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/evidencenow/heart-health/aspirin/pcor.html
     August 01, 2018 - patient-centered outcomes research (PCOR) findings and guidelines for aspirin use in people at high risk of heart disease

258. Search Evidence-Based Reports | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
     November 01, 2020 - Disorders (31) Genetic Conditions (10) Health Information Technology (21) Heart and Vascular Disease … (94) Infectious Diseases (55) Kidney and Urological Conditions (28) Laboratory Testing … Product Affiliation: Scientific Resource Center Report Status: Final End-Stage Renal Disease

259. EvidenceNow Executive Summary - Northwest Cooperative (pdf file)
     www.cpsi.ahrq.gov/sites/default/files/wysiwyg/evidencenow/cooperatives/evidencenow-executive-summary-northwest.pdf
     November 01, 2017 - care practices have the evidence they need to help their patients adopt the ABCS of cardiovascular disease … the educational outreach intervention learned about team-based implementation of a cardiovascular disease … EvidenceNOW Initiative [STFM Conference on Practice Improvement, 2017] 1 Mortality Data, Centers for Disease

260. Recently Funded Career Development Award Grants | Agency for Healthcare Research and Quality
     www.cpsi.ahrq.gov/funding/training-grants/grants/active/kawards/kawards.html
     July 01, 2019 - HS017723 University of California, San Francisco Measurement of Decision Quality in Coronary Artery Disease … HS018984 Medical University of South Carolina Improving Recognition and Management of Chronic Kidney Disease … Morgan, Daniel K08 HS018111 University of Maryland, Baltimore Improving Patient Safety and Disease